|
KIAA0406 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.11022302462516E-16 |
| Normal-vs-Stage2 |
6.75519999937535E-08 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.82853732155763E-12 |
| Stage1-vs-Stage2 |
6.017800E-01 |
| Stage1-vs-Stage3 |
9.142900E-03 |
| Stage1-vs-Stage4 |
6.373900E-02 |
| Stage2-vs-Stage3 |
3.076000E-02 |
| Stage2-vs-Stage4 |
7.350500E-02 |
| Stage3-vs-Stage4 |
8.893000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-16 |
| Normal-vs-AfricanAmerican |
2.02870000000077E-05 |
| Normal-vs-Asian |
2.15650053370098E-10 |
| Caucasian-vs-AfricanAmerican |
2.449800E-01 |
| Caucasian-vs-Asian |
5.454200E-01 |
| AfricanAmerican-vs-Asian |
4.984200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.7715611723761E-16 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
6.107400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.77770020926005E-11 |
| Normal-vs-Age(41-60Yrs) |
4.44089209850063E-16 |
| Normal-vs-Age(61-80Yrs) |
1.2134737659153E-13 |
| Normal-vs-Age(81-100Yrs) |
7.50310000000587E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.561000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.719900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.305000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.333400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.718600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.904400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.207950E-04 |
| Classical-VS-Follicular |
4.051000E-01 |
| Classical-VS-Other |
4.336200E-01 |
| Classical-VS-Normal |
6.23250340225923E-11 |
| Tall-VS-Follicular |
9.657500E-03 |
| Tall-VS-Other |
5.159800E-01 |
| Tall-VS-Normal |
9.32587340685131E-15 |
| Follicular-VS-Other |
7.084400E-01 |
| Follicular-VS-Normal |
1.65070179747318E-11 |
| Other-VS-Normal |
9.165400E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
3.10729220132089E-12 |
| N0-vs-N1 |
2.482200E-01 |
|
|
